CK LIFE Aktie

 

Um den gesamten Artikel unter aastocks.com zu lesen, klicken Sie bitte auf die Überschrift...

CKLIFE SCIENCES (00775.HK) announced that the Company will present new data from preclinical studies of investigational cancer vaccines at the 2025 American Association for Cancer Research (AACR) Annual Meeting in Chicago, USA. The said cancer vaccines target PRAME (Preferentially Expressed Antigen in Melanoma), PD-L1 (programme......

FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE. THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE: INSTRUMENT NAME KUERZEL/SHORTCODE ISIN CK LIFE SCIENCES HD-,10 LSI KYG2176J1058 AB/FROM ONWARDS 11.04.2025...

CKLIFE SCIENCES (00775.HK) resumed trading of its shares today (11th), and once leapfrogged as high as nearly 42% to a high of $0.68. The stock last printed at $0.61, up 27.08%, with 16.627 million shares traded, involving $10.8023 million.CKLIFE SCIENCES obtained promising early results in laboratory tests of its preclinical st......

DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT: THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT: INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTIL CK LIFE SCIENCES HD-,10 LSI KYG2176J1058 BAW/UFN...

Instrument ID [6636] (LSI - KYG2176J1058) suspended...

At the request of CKLIFE SCIENCES (00775.HK), trading in the shares of the Company has been halted with effect from 9:00 a.m. on Thursday (10th) pending the release of an announcement by the Company. ~AAStocks Financial NewsWeb Site: www.aastocks.com...

CKLIFE SCIENCES (00775.HK) announced that trading in its shares has been halted since 9:00 am on Thursday (10th), with the reason still veiled.~AAStocks Financial NewsWeb Site: www.aastocks.com...

As at 24 March, the public float of CKLIFE SCIENCES (00775.HK) has been restored to above the minimum percentage of 25% prescribed under Rule 8.08(1)(a) of the Rules Governing the Listing of Securities on the Stock Exchange, according to CKLIFE SCIENCES' announcement. Currently, the shareholding of CKH HOLDINGS (00001.HK)/ L......

Largest shareholder, CK Life Sciences Int'l., (Holdings) Inc. agrees to conversion of debt into equity, removing all existing debt from Dogwood's balance sheet Largest shareholder, CK Life Sciences Int'l., (Holdings) Inc. agrees to conversion of debt into equity, removing all existing debt from Dogwood's balance sheet...

The company said the loss for 2024 could come in at HK$126.6 million (US$16.3 million) versus a profit of HK$17.3 million the previous year....

CK Life Sciences made a decision that has reaped rewards for fifteen years...

CK ASSET (01113.HK) is partnering with CKH HOLDINGS (00001.HK), through CKLIFE SCIENCES (00775.HK), a member company of CKH HOLDINGS, collectively known as the "CK Group", to venture into the field of regenerative agriculture, with investment emphasis on carbon sequestration projects to store carbon.Kam Hing Lam, Deput......

CKLIFE SCIENCES (00775.HK) announced that its subsidiary WEX Pharmaceuticals entered into a business merger with Nasdaq-listed biotech company Virios Therapeutics (VIRI.US). Upon completion of the transaction, CKLIFE SCIENCES will hold approximately 15.9% of VIRI's shares and be granted convertible preferred stock. The share......

ATLANTA and VANCOUVER, British Columbia, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Virios Therapeutics, Inc. (NASDAQ: VIRI) (the “Company”), and Wex Pharmaceuticals, Inc. (“WEX”), a wholly owned subsidiary of CK Life Sciences Int'l., (Holdings) Inc. (“CKLS”), today announced that Virios has entered into a definitive share exchange agreement with Sealbond Limited, an indirect parent of Wex, pursuant to which the companies will combine in an all-stock transaction (the “Combination”)....

CKLIFE SCIENCES (00775.HK) held its annual general meeting (AGM), at which Chairman Li Tzar Kuoi, Victor said that the decline in last year's profit was attributable to a hike of $159 million in finance costs, which far topped the increase of $23.1 million in profit before tax and finance costs. If interest rates are maintai......